Trajan Group Reports Record Q2 Earnings

The analytical and life sciences company reaffirmed its full-year guidance after a strong second quarter.

Published on Feb. 26, 2026

Got story updates? Submit your updates here. ›

Trajan Group (ASX:TRJ) reported first-half results that were shaped by a weak first quarter, followed by a 'record' second quarter that helped restore confidence in the company's outlook. CEO Steven said the company was 'yet again' reconfirming guidance, which implies 'another record year' for group revenue. Trajan maintained its expectation for revenue of more than AUD 170 million and normalized EBITDA above AUD 16 million for FY26.

Why it matters

Trajan's strong second quarter performance and reaffirmed guidance suggest the company is weathering macroeconomic volatility and continuing to grow its analytical and life sciences business. The company's investments in manufacturing and inventory improvements also indicate it is positioning itself for future demand.

The details

In the first quarter, Trajan saw a slowdown in capital equipment orders and tariff-related timing headwinds, but by the second quarter, performance improved. Steven described Q2 as a 'record quarter' with revenue of 'over AUD 45 million.' The company's components and consumables segment saw a 6.1% increase in net revenue, while capital equipment revenue declined 2.7% year-over-year. Trajan's disruptive technologies segment grew 40.2% in revenue. The company also cited investments in 'in-region, for-region' manufacturing and increased inventory to improve delivery performance.

  • In the first quarter, Trajan saw a slowdown in capital equipment orders and tariff-related timing headwinds.
  • In the second quarter, Trajan reported a 'record quarter' with revenue of 'over AUD 45 million.'

The players

Trajan Group

An Australian analytical and life sciences company that develops, manufactures, sells, and distributes products and devices.

Steven

The CEO of Trajan Group.

Alister

A Trajan Group executive who provided financial details during the earnings call.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

What’s next

The company said it expects to see further margin improvement as it reduces certain purchased components while ensuring no negative impact on analytical performance or customers.

The takeaway

Trajan's strong second-quarter performance and reaffirmed guidance demonstrate the company's resilience in the face of macroeconomic challenges. Its investments in manufacturing and inventory improvements position it well for future growth in the analytical and life sciences sectors.